Background Angiogenesis plays a role in the biology of ovarian cancer. We examined the
effect of bevacizumab, the vascular endothelial growth factor inhibitor, on survival in women …

Introduction The persistence of circulating tumor cells (CTC) in breast cancer patients might
be associated with stem cell like tumor cells which have been suggested to be the active …

Purpose Most patients with advanced ovarian cancer develop recurrent disease. For those
patients who recur at least 6 months after initial therapy, paclitaxel platinum has shown a …

Background Systematic pelvic and paraaortic lymphadenectomy has been widely used in the
surgical treatment of patients with advanced ovarian cancer, although supporting evidence …

Objective Polycystic ovary syndrome (PCOS) has been shown to cause a reduction in
quality of life. This study examines the extent of different PCOS symptoms on quality-of-life, …

Purpose Pazopanib is an oral, multikinase inhibitor of vascular endothelial growth factor
receptor (VEGFR) -1/-2/-3, platelet-derived growth factor receptor (PDGFR) -α/-β, and c-Kit. …

Introduction The presence of circulating tumor cells (CTC) in breast cancer might be associated
with stem cell-like tumor cells which have been suggested to be the active source of …

We have developed a novel single-chain Ep-CAM-/CD3-bispecific single-chain antibody
construct designated MT110. MT110 redirected unstimulated human peripheral T cells to …

Purpose: Malignant ascites in ovarian carcinoma patients is associated with poor prognosis
and reduced quality of life. The trifunctional antibody catumaxomab (anti-EpCAM × anti-CD3…

Introduction The role of circulating tumor cells (CTCs) in blood of primary breast cancer
patients is still under investigation. We evaluated the incidence of CTCs in blood, we evaluated …